ENTRY       D12426                      Drug
NAME        Itolizumab (USAN/INN)
FORMULA     C6440H10020N1714O2023S44
EXACT_MASS  145144.1591
MOL_WEIGHT  145233.5968
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVKPGGSLKL SCAASGFKFS RYAMSWVRQA PGKRLEWVAT ISSGGSYIYY
            PDSVKGRFTI SRDNVKNTLY LQMSSLRSED TAMYYCARRD YDLDYFDSWG QGTLVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASRDIR SYLTWYQQKP GKAPKTLIYY ATSLADGVPS
            RFSGSGSGQD YSLTISSLES DDTATYYCLQ HGESPFTLGS GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Immunomodulator
  TYPE      Monoclonal antibody
COMMENT     Treatment of autoimmune and inflammatory diseases
TARGET      CD6 (TP120) [HSA:923] [KO:K06456]
  PATHWAY   hsa04514(923)  Cell adhesion molecules
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD6 (TP120)
                 D12426  Itolizumab (USAN/INN)
DBLINKS     CAS: 1116433-11-4
///
